Aesculap AG Sustainability Profile
Aesculap AG, a prominent subsidiary of B. Braun Melsungen AG, is headquartered in Tuttlingen, Germany. Established in 1867, the company has evolved into a leader in the medical technology industry, specialising in surgical instruments, implants, and sterile supply management. Aesculap AG is renowned for its innovative solutions in areas such as neurosurgery, orthopaedics, and cardiovascular surgery. With a strong presence in Europe, Asia, and the Americas, Aesculap AG has achieved significant milestones, including the development of advanced surgical techniques and products that enhance patient safety and surgical outcomes. The company’s commitment to quality and precision has solidified its market position, making it a trusted partner for healthcare professionals worldwide. Aesculap AG continues to set benchmarks in the medical field, driven by a dedication to innovation and excellence.
DitchCarbon Score
How does Aesculap AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aesculap AG's score of 31 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aesculap AG's reported carbon emissions
Aesculap AG, headquartered in Germany (DE), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of B. Braun Holding GmbH & Co. KG, which may influence its climate commitments and performance metrics. While Aesculap AG has not outlined specific reduction targets or initiatives, it is important to note that it is part of a larger corporate family that may have established sustainability goals. However, no details regarding Science-Based Targets Initiative (SBTi) commitments or other climate pledges have been provided. As the company continues to navigate its environmental responsibilities, it remains essential for Aesculap AG to align with industry standards and best practices in climate action, particularly in the medical technology sector.
How Carbon Intensive is Aesculap AG's Industry?
How Carbon Intensive is Aesculap AG's Location?
Aesculap AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aesculap AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
